Cite

    Fernández-Fournier, M., Kerguelen, A., Rodríguez de Rivera, F. J., Lacruz, L., Jimeno, S., Losantos, I., Hernández-Maraver, D., Puertas, I., Tallon-Barranco, A., Viejo, A., Frank García, A., & Díez-Tejedor, E. (2022). therapeutic plasma exchange for myasthenia gravis, Guillain-Barre syndrome, and other immune-mediated neurological diseases, over a 40-year experience. Expert review of neurotherapeutics, 22, 897–903. http://access.bl.uk/ark:/81055/vdc_100172218250.0x000025